Monica Arvidsson

1.1k total citations
21 papers, 827 citations indexed

About

Monica Arvidsson is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Monica Arvidsson has authored 21 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 15 papers in Immunology and Allergy and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Monica Arvidsson's work include Asthma and respiratory diseases (17 papers), Allergic Rhinitis and Sensitization (13 papers) and Food Allergy and Anaphylaxis Research (7 papers). Monica Arvidsson is often cited by papers focused on Asthma and respiratory diseases (17 papers), Allergic Rhinitis and Sensitization (13 papers) and Food Allergy and Anaphylaxis Research (7 papers). Monica Arvidsson collaborates with scholars based in Sweden, Finland and Denmark. Monica Arvidsson's co-authors include S. Rak, O. Löwhagen, Peter Adler Würtzen, Kaare Lund, G. Lund, Hans Henrik Ipsen, Lars K. Poulsen, C. André, Alexander Kavina and Michel Mélac and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Nutrients.

In The Last Decade

Monica Arvidsson

21 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monica Arvidsson Sweden 14 670 596 305 120 74 21 827
Louisa K. Wilcock United Kingdom 7 726 1.1× 654 1.1× 374 1.2× 64 0.5× 143 1.9× 10 895
Giannis Paraskevopoulos United Kingdom 6 417 0.6× 341 0.6× 213 0.7× 31 0.3× 66 0.9× 8 496
Jürgen Reisinger Austria 9 603 0.9× 481 0.8× 249 0.8× 44 0.4× 72 1.0× 11 735
Marina Tsoumani United Kingdom 7 277 0.4× 198 0.3× 110 0.4× 30 0.3× 71 1.0× 7 349
Tomokazu Matsuoka Japan 11 230 0.3× 196 0.3× 121 0.4× 41 0.3× 70 0.9× 31 402
François-B. Michel France 4 228 0.3× 289 0.5× 110 0.4× 126 1.1× 71 1.0× 4 387
Peter Kopač Slovenia 13 450 0.7× 136 0.2× 222 0.7× 25 0.2× 155 2.1× 35 630
Toshioki Sakurai Japan 10 200 0.3× 198 0.3× 74 0.2× 31 0.3× 88 1.2× 18 305
Johann-Christian Virchow Switzerland 4 225 0.3× 593 1.0× 66 0.2× 187 1.6× 349 4.7× 5 709
Katharina Gangl Austria 10 161 0.2× 130 0.2× 53 0.2× 32 0.3× 33 0.4× 17 269

Countries citing papers authored by Monica Arvidsson

Since Specialization
Citations

This map shows the geographic impact of Monica Arvidsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Arvidsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Arvidsson more than expected).

Fields of papers citing papers by Monica Arvidsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Arvidsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Arvidsson. The network helps show where Monica Arvidsson may publish in the future.

Co-authorship network of co-authors of Monica Arvidsson

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Arvidsson. A scholar is included among the top collaborators of Monica Arvidsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Arvidsson. Monica Arvidsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Odijk, Jenny van, et al.. (2023). The Use of DAO as a Marker for Histamine Intolerance: Measurements and Determinants in a Large Random Population-Based Survey. Nutrients. 15(13). 2887–2887. 9 indexed citations
2.
Pullerits, Teet, Erik Rönmark, Linda Ekerljung, et al.. (2020). The triad of current asthma, rhinitis and eczema is uncommon among adults: Prevalence, sensitization profiles, and risk factors. Respiratory Medicine. 176. 106250–106250. 14 indexed citations
3.
Ternestén‐Hasseus, Ewa, et al.. (2018). Small and large airway reactions to osmotic stimuli in asthma and chronic idiopathic cough. Pulmonary Pharmacology & Therapeutics. 49. 112–118. 4 indexed citations
4.
Konradsen, Jon R. & Monica Arvidsson. (2016). [Allergen-specific immunotherapy provides long-lasting symptom relief].. PubMed. 113. 3 indexed citations
5.
Nony, Emmanuel, Julien Bouley, Maxime Le Mignon, et al.. (2015). Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen‐allergic patients. Allergy. 70(7). 795–804. 53 indexed citations
6.
Ekoff, Maria, Katarina Lyberg, Maryla Krajewska, et al.. (2012). Anti-Apoptotic Bfl-1 Is the Major Effector in Activation-Induced Human Mast Cell Survival. PLoS ONE. 7(6). e39117–e39117. 16 indexed citations
7.
8.
Pauli, Gabrielle, S. Rak, Friedrich Horak, et al.. (2008). Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. Journal of Allergy and Clinical Immunology. 122(5). 951–960. 230 indexed citations
9.
Würtzen, Peter Adler, G. Lund, Kaare Lund, et al.. (2008). A double‐blind placebo‐controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation. Clinical & Experimental Allergy. 38(8). 1290–1301. 85 indexed citations
10.
11.
Arvidsson, Monica, et al.. (2006). Production of interleukin-12 by monocytes and interferon-γ by natural killer cells in allergic patients during rush immunotherapy. Annals of Allergy Asthma & Immunology. 97(4). 464–468. 12 indexed citations
12.
Arvidsson, Monica, et al.. (2006). Basophil Interleukin 4 and Interleukin 13 Production Is Suppressed during the Early Phase of Rush Immunotherapy. International Archives of Allergy and Immunology. 141(4). 346–353. 53 indexed citations
13.
Arvidsson, Monica, et al.. (2004). The effect of specific immunotherapy on the expression of costimulatory molecules in late phase reaction of the skin in allergic patients. Clinical & Experimental Allergy. 34(12). 1862–1867. 5 indexed citations
14.
Löwhagen, O., Monica Arvidsson, Barbro Balder, et al.. (2004). Haplotypes of the interleukin‐4 receptor α chain gene associate with susceptibility to and severity of atopic asthma. Clinical & Experimental Allergy. 34(10). 1570–1575. 46 indexed citations
15.
Neerven, R. J. Joost van, Monica Arvidsson, H. Ipsen, et al.. (2004). A double‐blind, placebo‐controlled birch allergy vaccination study: inhibition of CD23‐mediated serum‐immunoglobulin E‐facilitated allergen presentation. Clinical & Experimental Allergy. 34(3). 420–428. 64 indexed citations
16.
17.
Löwhagen, O., Monica Arvidsson, & K. Pettersson. (2002). Asthma and asthma-like disorder, a 5-year follow-up study. Respiratory Medicine. 96(12). 1040–1044. 3 indexed citations
18.
Arvidsson, Monica, Karin Petruson, Kenneth Holmberg, et al.. (2002). The effect of omalizumab on nasal allergic inflammation. Journal of Allergy and Clinical Immunology. 110(1). 68–71. 83 indexed citations
19.
Arvidsson, Monica, O. Löwhagen, & S. Rak. (2002). Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy. Journal of Allergy and Clinical Immunology. 109(5). 777–783. 51 indexed citations
20.
Löwhagen, O., et al.. (1999). Exercise-induced respiratory symptoms are not always asthma. Respiratory Medicine. 93(10). 734–738. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louisa K. Wilcock Breakdown of academic impact, for papers by Giannis Paraskevopoulos Breakdown of academic impact, for papers by Jürgen Reisinger Breakdown of academic impact, for papers by Marina Tsoumani Breakdown of academic impact, for papers by Tomokazu Matsuoka Breakdown of academic impact, for papers by François-B. Michel Breakdown of academic impact, for papers by Peter Kopač Breakdown of academic impact, for papers by Toshioki Sakurai Breakdown of academic impact, for papers by Johann-Christian Virchow Breakdown of academic impact, for papers by Katharina Gangl
Rankless by CCL
2026